Avanza Fonder AB grew its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 23.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,157 shares of the semiconductor company’s stock after buying an additional 2,299 shares during the quarter. Avanza Fonder AB’s holdings in Synopsys were worth $5,998,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in SNPS. Symphony Financial Ltd. Co. increased its stake in Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares in the last quarter. HBW Advisory Services LLC grew its holdings in shares of Synopsys by 494.9% in the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after buying an additional 3,004 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of Synopsys by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock worth $691,035,000 after acquiring an additional 4,815 shares in the last quarter. Westbourne Investments Inc. acquired a new stake in shares of Synopsys during the second quarter worth about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Synopsys by 1.7% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock valued at $91,660,000 after purchasing an additional 2,991 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on SNPS. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Robert W. Baird reiterated a “neutral” rating and set a $535.00 target price (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Rosenblatt Securities raised Synopsys from a “neutral” rating to a “buy” rating and dropped their target price for the company from $605.00 to $560.00 in a research report on Tuesday, December 9th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Eleven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $562.13.
Synopsys Stock Performance
NASDAQ SNPS opened at $475.50 on Friday. The firm has a market capitalization of $90.97 billion, a P/E ratio of 59.51, a price-to-earnings-growth ratio of 3.96 and a beta of 1.16. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The firm’s fifty day moving average price is $436.99 and its two-hundred day moving average price is $503.73. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same period in the previous year, the business earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Activity at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
- 33,000% boom from weird new “AI Fuel?”
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
